512217 — Prism Medico and Pharmacy Share Price
- IN₹142.49m
- IN₹141.94m
- IN₹12.71m
- 31
- 35
- 25
- 16
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.13 | ||
Price to Tang. Book | 1.13 | ||
Price to Free Cashflow | 4.82 | ||
Price to Sales | 3.52 | ||
EV to EBITDA | 270.36 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 0.39% | ||
Return on Equity | 0.77% | ||
Operating Margin | 1.2% |
Financial Summary
Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 544.28 | 268.9 | 167.64 | 84.44 | 12.71 | n/a | n/a | -43.87% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -9.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Prism Medico and Pharmacy Limited is an India-based company that is engaged in wholesaling and retailing of straw, fodder and other animal/poultry feed as well as its manufacturing, buying, dealing, export, importing, and trading. The Company acts as wholesaler, retailer, suppliers, selling agent, buying agent, repackers, analytical chemists, druggist, refiners, processors, merchants and stockiest for various types of chemicals, serums, chemical products, antibiotics, medicines, drugs, pharmaceuticals pesticide, dyes, soaps oil, perfumes, cosmetic, and patent medicine. The Company has not been able to carry out any operations. It is presently engaged in trading.
Directors
- Sameer Gupta CCO (34)
- Sachin Sharma EDR
- Jasjot Singh EDR (33)
- Anand Dubey DRC (52)
- Virendrakumar Jain DRC (53)
- Rishi Panwar DRC
- Ramandeep Singh DRC
- Sehejbir Bhatia NED
- Pallav Parajulee IND
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 22nd, 2002
- Public Since
- July 29th, 2005
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 6,063,428
- Address
- D-118, Industrial Area, Phase-Vii, MOHALI, 160055
- Web
- https://www.prismmedico.in/
- Phone
- +91 1725020762
- Auditors
- Harjeet Parvesh & Co.
Upcoming Events for 512217
Similar to 512217
Aayush Food and Herbs
Bombay Stock Exchange
Acewin Agriteck
Bombay Stock Exchange
Ajanta Soya
Bombay Stock Exchange
Alna Trading and Exports
Bombay Stock Exchange
Ambar Protein Industries
Bombay Stock Exchange
FAQ
As of Today at 13:18 UTC, shares in Prism Medico and Pharmacy are trading at IN₹23.50. This share price information is delayed by 15 minutes.
Shares in Prism Medico and Pharmacy last closed at IN₹23.50 and the price had moved by -23.45% over the past 365 days. In terms of relative price strength the Prism Medico and Pharmacy share price has underperformed the S&P BSE 100 Index by -40.53% over the past year.
There is no consensus recommendation for this security.
Prism Medico and Pharmacy does not currently pay a dividend.
Prism Medico and Pharmacy does not currently pay a dividend.
Prism Medico and Pharmacy does not currently pay a dividend.
To buy shares in Prism Medico and Pharmacy you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹23.50, shares in Prism Medico and Pharmacy had a market capitalisation of IN₹142.49m.
Here are the trading details for Prism Medico and Pharmacy:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 512217
Based on an overall assessment of its quality, value and momentum Prism Medico and Pharmacy is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Prism Medico and Pharmacy. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -32.32%.
As of the last closing price of IN₹23.50, shares in Prism Medico and Pharmacy were trading -15.22% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Prism Medico and Pharmacy PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹23.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Prism Medico and Pharmacy's management team is headed by:
- Sameer Gupta - CCO
- Sachin Sharma - EDR
- Jasjot Singh - EDR
- Anand Dubey - DRC
- Virendrakumar Jain - DRC
- Rishi Panwar - DRC
- Ramandeep Singh - DRC
- Sehejbir Bhatia - NED
- Pallav Parajulee - IND